Skip to content

Study of Patolkaturohinyadi kashaya as Samshodhan dravya(Virechan) in Kitibha(Psoriasis).

Evaluation of Samshodhan Siddhanta In Raktaj Vyadhi w.s.r to Kitibha (Psoriasis)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042817
Enrollment
50
Registered
2022-05-25
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

None listed

Sponsors

Department Of Siddhanta Darshan
Lead Sponsor
Department Of Panchkarma
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age group between 18-60 years. 2 Classical Features & Diagnosed cases of Kitibha (Psoriasis) 3 Patients willing to participate in above mentioned trial and giving informed consent

Exclusion criteria

Exclusion criteria: 1.Age group less than 18 years and more than 60 years. 2.Psoriatic patients with other systemic disease like Hypertension. Anemia, Diabetes Mellitus, Asthma, Jaundice. Cardiac diseases, HIV etc . 3.Patient has donated more than 500ml of blood within last month. 4.Patient has suffered a serious bacterial infection. 5.Pregnant and lactating women. 6 Patients with psoriatic complications. 7 Patients taking other drugs for the treatment of psoriasis.

Design outcomes

Primary

MeasureTime frame
Pasi Score CBC ESR RBSTimepoint: Three Months with 3 follow ups of one month.

Secondary

MeasureTime frame
to evaluate effect of patolkaturohinyadi kashaya as samshodhan dravya (virechan)in kitibha(psoriasis)Timepoint: Three months with three follow ups of one month.

Countries

India

Contacts

Public ContactDr Chandra Shekhar Pandey

Banaras Hindu University

cspandey@bhu.ac.in9415361140

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026